Soo Jeong Kim1, Omar Al Hussein Alawamlh1, Bilal Chughtai1, Richard K Lee2. 1. Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical Center, 425 East 61st St, 12th Floor, New York, NY, 10065, USA. 2. Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical Center, 425 East 61st St, 12th Floor, New York, NY, 10065, USA. ril9010@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: Transurethral resection of the prostate (TURP) is the standard surgical therapy for lower urinary tract symptoms (LUTS) due to prostatic enlargement. Following TURP, LUTS may persist in a proportion of patients. Persistent LUTS necessitates proper evaluation and management. In this review, we sought to describe the prevalence, pathophysiology, and predictors of LUTS following TURP, as well as the recommended evaluation and management. RECENT FINDINGS: Among the different techniques utilized for TURP, the prevalence of postoperative LUTS is similar. The chronically obstructed bladder has been shown to vary in its expression of collagen, tissue factors, and receptors when compared to the normal bladder which could contribute to the pathophysiology of LUTS after TURP. Although androgen receptors exist in the urinary epithelium, the role of sex hormones in LUTS remains obscure. GreenLight laser can lead to postoperative irritative voiding symptoms as a result of tissue necrosis. A large proportion of patients have persistent LUTS following TURP, with similar incidences between different techniques that can be used to perform TURP. LUTS after TURP should be evaluated with a thorough history and physical, including International Prostate Symptom Score, and urine culture to rule out infection. Noninvasive uroflow, post-void residuals, and subsequent urodynamic study or cystoscopy can be utilized as needed. Further research is necessary to be able to more precisely predict the patients who will experience no improvement in or worsening of LUTS following TURP.
PURPOSE OF REVIEW: Transurethral resection of the prostate (TURP) is the standard surgical therapy for lower urinary tract symptoms (LUTS) due to prostatic enlargement. Following TURP, LUTS may persist in a proportion of patients. Persistent LUTS necessitates proper evaluation and management. In this review, we sought to describe the prevalence, pathophysiology, and predictors of LUTS following TURP, as well as the recommended evaluation and management. RECENT FINDINGS: Among the different techniques utilized for TURP, the prevalence of postoperative LUTS is similar. The chronically obstructed bladder has been shown to vary in its expression of collagen, tissue factors, and receptors when compared to the normal bladder which could contribute to the pathophysiology of LUTS after TURP. Although androgen receptors exist in the urinary epithelium, the role of sex hormones in LUTS remains obscure. GreenLight laser can lead to postoperative irritative voiding symptoms as a result of tissue necrosis. A large proportion of patients have persistent LUTS following TURP, with similar incidences between different techniques that can be used to perform TURP. LUTS after TURP should be evaluated with a thorough history and physical, including International Prostate Symptom Score, and urine culture to rule out infection. Noninvasive uroflow, post-void residuals, and subsequent urodynamic study or cystoscopy can be utilized as needed. Further research is necessary to be able to more precisely predict the patients who will experience no improvement in or worsening of LUTS following TURP.
Entities:
Keywords:
Benign prostatic hyperplasia; Lower urinary tract symptoms; Persistent LUTS; Transurethral resection of the prostate
Authors: Alberto Azoubel Antunes; Alexandre Iscaife; Sabrina Thalita Reis; Aline Albertini; Marco Antonio Nunes; Antonio Marmo Lucon; William Carlos Nahas; Miguel Srougi Journal: J Urol Date: 2015-01-09 Impact factor: 7.450
Authors: Germar-M Pinggera; Michael Mitterberger; Leo Pallwein; Antonius Schuster; Ralf Herwig; Ferdinand Frauscher; Georg Bartsch; Hannes Strasser Journal: BJU Int Date: 2007-11-13 Impact factor: 5.588